IRIS
CANDIDO, SAVERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.498
EU - Europa 1.845
AS - Asia 1.631
SA - Sud America 417
AF - Africa 288
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.378
IT - Italia 780
SG - Singapore 679
CN - Cina 623
IE - Irlanda 383
BR - Brasile 376
CI - Costa d'Avorio 215
UA - Ucraina 198
DE - Germania 155
VN - Vietnam 100
CA - Canada 97
RU - Federazione Russa 83
FI - Finlandia 43
IN - India 42
KR - Corea 40
SN - Senegal 36
GB - Regno Unito 34
SE - Svezia 34
BD - Bangladesh 26
FR - Francia 24
NL - Olanda 21
AR - Argentina 18
TR - Turchia 18
CH - Svizzera 17
MX - Messico 17
AT - Austria 14
IQ - Iraq 14
ZA - Sudafrica 14
PL - Polonia 13
HK - Hong Kong 12
ID - Indonesia 11
JP - Giappone 11
ES - Italia 10
UZ - Uzbekistan 10
IR - Iran 8
NG - Nigeria 8
PK - Pakistan 8
VE - Venezuela 6
BE - Belgio 5
BG - Bulgaria 5
GR - Grecia 5
NP - Nepal 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CO - Colombia 4
KZ - Kazakistan 4
RO - Romania 4
TN - Tunisia 4
AU - Australia 3
EC - Ecuador 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
BY - Bielorussia 2
CL - Cile 2
CM - Camerun 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
LT - Lituania 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
HR - Croazia 1
KI - Kiribati 1
LI - Liechtenstein 1
MA - Marocco 1
MU - Mauritius 1
PH - Filippine 1
SI - Slovenia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.685
Salva come PNG Salva come JPEG
Città #
Dallas 1.146
Santa Clara 659
Chandler 420
Singapore 410
Dublin 375
Jacksonville 278
Catania 223
Chicago 216
Abidjan 215
Boardman 151
Beijing 122
Ashburn 100
Cambridge 100
Lawrence 100
Hefei 94
Andover 91
Grafing 84
Nanjing 82
Toronto 72
Los Angeles 63
Houston 58
Des Moines 55
Wilmington 52
Dong Ket 47
Civitanova Marche 43
Palermo 41
Seoul 38
Dakar 36
São Paulo 31
Columbus 30
Council Bluffs 30
San Mateo 30
The Dalles 28
Hebei 27
Nanchang 25
New York 25
Helsinki 23
Rome 23
Saint Petersburg 22
Hanoi 19
Shenyang 19
Ho Chi Minh City 17
Messina 17
Jiaxing 16
Falls Church 14
Lappeenranta 14
Acireale 13
Bremen 13
Guangzhou 13
Naples 13
Rio de Janeiro 13
Belo Horizonte 12
Dearborn 12
Hong Kong 12
Padova 12
Milan 11
Ottawa 11
Munich 10
Tokyo 10
Augusta 9
Mexico City 9
Nuremberg 9
Redwood City 9
Tianjin 9
Warsaw 9
Abuja 8
Aci Catena 8
Curitiba 8
Frankfurt am Main 8
Jinan 8
Johannesburg 8
Mascalucia 8
Norwalk 8
Baghdad 7
Boston 7
Brooklyn 7
Changsha 7
Florence 7
Kochi 7
Leawood 7
Mumbai 7
San Francisco 7
Den Haag 6
Frankfurt Am Main 6
London 6
Porto Alegre 6
Redmond 6
Seattle 6
Turku 6
Amsterdam 5
Ankara 5
Ardabil 5
Cape Town 5
Chennai 5
Da Nang 5
Genoa 5
Istanbul 5
Jakarta 5
Maletto 5
Misterbianco 5
Totale 6.214
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 217
Advances in targeting signal transduction pathways. 184
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 135
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 131
Computational modelling in melanoma for novel drug discovery 130
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 127
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 127
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 125
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 123
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 121
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 121
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 119
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 113
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 113
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 112
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 111
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 107
Prognostic significance of deregulated microRNAs in uveal melanomas 107
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 104
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 102
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 102
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 101
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 100
Cutaneous melanoma: From pathogenesis to therapy 98
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 98
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 97
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 96
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 96
microRNAs and thyroid cancer: Biological and clinical significance (Review). 94
Nitric Oxide in Hematological Cancers: Partner or Rival? 94
Environment and bladder cancer: Molecular analysis by interaction networks 93
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 93
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 92
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 92
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 91
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 89
Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer 87
Emerging targeted therapies for melanoma treatment (review) 87
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 85
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 85
Pericytes in microvessels: From “mural” function to brain and retina regeneration 83
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 82
Dysregulation of IL-6 cis- and trans-signaling and high frequency of IL6R rs2228145(C>A) in the management of Deep Vein Thrombosis 78
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 78
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review) 75
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 74
Cutaneous melanoma and the immunotherapy revolution (Review) 73
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 72
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 71
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 70
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 70
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 70
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 69
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 69
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 69
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 68
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 68
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 68
Cancer therapy and treatments during COVID-19 era 68
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 66
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 66
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer 66
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 65
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 65
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 65
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 64
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 63
Suppressing prostate cancer by targeting NGAL 62
Targeting signaling pathways involved in metastasis in cancer stem cells 62
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 61
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 61
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 60
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 60
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 59
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 58
Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 58
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 57
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 56
The tumor microenvironment in hepatocellular carcinoma 56
Neopterin: a potential marker in chronic peripheral arterial disease 55
Metformin influences drug sensitivity in pancreatic cancer cells 55
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 55
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 55
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 54
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 54
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 54
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 53
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 53
YY1 silencing induces 5-fluorouracil-resistance and BCL2L15 downregulation in colorectal cancer cells: Diagnostic and prognostic relevance 53
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer 52
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 52
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines 52
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 51
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 51
Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer 51
Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review) 50
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 50
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 50
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways 50
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 49
Totale 8.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021522 0 0 0 4 107 33 75 0 109 15 121 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024540 20 80 32 27 24 100 25 34 11 20 93 74
2024/20252.652 24 390 143 142 589 286 131 103 210 266 176 192
2025/20262.260 328 511 1.073 348 0 0 0 0 0 0 0 0
Totale 8.876